title: Intensive glucose lowering and cardiovascular outcomes.
authors.forename: Almut G
authors.initials: AG
authors.lastname: Winterstein
authors.forename: Susan R
authors.initials: SR
authors.lastname: Heckbert
authors.forename: Morris
authors.initials: M
authors.lastname: Schambelan
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000077154:Rosiglitazone; D045162:Thiazolidinediones